Lecturas recomendadas

  • Andrade JG, Wells GA, Deyell MW, Bennett M, Essebag V, Champagne J, Roux JF, Yung D, Skanes A, Khaykin Y, Morillo C, Jolly U, Novak P, Lockwood E, Amit G, Angaran P, Sapp J, Wardell S, Lauck S, Macle L, Verma A; EARLY-AF Investigators. Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation. N Engl J Med. 2021 Jan 28;384(4):305-315. doi: 10.1056/NEJMoa2029980. Epub 2020 Nov 16. PMID: 33197159.
  • Boas R, Thune JJ, Pehrson S, Køber L, Nielsen JC, Videbæk L, Haarbo J, Korup E, Bruun NE, Brandes A, Eiskjær H, Thøgersen AM, Philbert BT, Svendsen JH, Dixen U. Atrial fibrillation is a marker of increased mortality risk in nonischemic heart failure-Results from the DANISH trial. Am Heart J. 2021 Feb;232:61-70. doi: 10.1016/j.ahj.2020.10.073. Epub 2020 Nov 2. PMID: 33144085.
  • Martínez-Sellés M, Elosua R, Ibarrola M, de Andrés M, Díez-Villanueva P, Bayés-Genis A, Baranchuk A, Bayés-de-Luna A; BAYES Registry Investigators. Advanced interatrial block and P-wave duration are associated with atrial fibrillation and stroke in older adults with heart disease: the BAYES registry. Europace. 2020 Jul 1;22(7):1001-1008. doi: 10.1093/europace/euaa114. PMID: 32449904.
  • Michaud GF, Stevenson WG. Atrial Fibrillation. N Engl J Med. 2021 Jan 28;384(4):353-361. doi: 10.1056/NEJMcp2023658. PMID: 33503344.
  • Torres Llergo J, Fernández Olmo MR, Carrillo Bailén M, Puentes Chiachio M. High use of direct oral anticoagulants in elderly patients with atrial fibrillation: data from the REFLEJA registry. Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):97-99. English, Spanish. doi: 10.1016/j.rec.2020.05.038. Epub 2020 Aug 8. PMID: 32782198.
  • Zink MD, Mischke KG, Keszei AP, Rummey C, Freedman B, Neumann G, Tolksdorf A, Frank F, Wienströer J, Kuth N, Schulz JB, Marx N. Screen-detected atrial fibrillation predicts mortality in elderly subjects. Europace. 2021 Jan 27;23(1):29-38. doi: 10.1093/europace/euaa190. PMID: 33020819; PMCID: PMC7842093.
  • Arbab-Zadeh A, Fuster V. From detecting the vulnerable plaque to managing the vulnerable patient: JACC state-of-the-art review. J Am Coll Cardiol 2019;74: 1582–1593.
  • Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007;356: 830–840.
  • Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018 Jan 7;39(2):119-177. doi: 10.1093/eurheartj/ehx393. PMID: 28886621.
  • Mehilli J, Presbitero P. Coronary artery disease and acute coronary syndrome in women. Heart. 2020 Apr;106(7):487-492. doi: 10.1136/heartjnl-2019-315555. Epub 2020 Jan 13. PMID: 31932287.
  • Mortensen MB, Nordestgaard BG. Comparison of five major guidelines for statin use in primary prevention in a contemporary general population. Ann Intern Med 2018;168:85–92.
  • National Institute for Health and Care Excellence (NICE): Lipid modification— Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. 2014. https://www. nice.org.uk/guidance (7 March 2020).
  • Pagidipati NJ, Coles A, Hemal K, Lee KL, Dolor RJ, Pellikka PA, et al. Sex differences in management and outcomes of patients with stable symptoms suggestive of coronary artery disease: insights from the PROMISE trial. Am Heart J 2019;208:28–36.
  • Rao S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011 Mar 3;364(9):829-841. doi: 10.1056/NEJMoa1008862.
  • Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al; PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011;364:226–235.
  • Svane J, Lynge TH, Pedersen-Bjergaard U, Jespersen T, Gislason GH, Risgaard B, Winkel BG, Tfelt-Hansen J. Cause-specific mortality in children and young adults with diabetes mellitus: a Danish Nationwide Cohort Study. Eur J Prev Cardiol 2019; doi:10.1177/204748731983655
  • Tomaniak M, Chichareon P, Onuma Y, Deliargyris EN, Takahashi K, Kogame N, et al; for the GLOBAL LEADERS Trial Investigators. Benefit and risks of aspirin in addition to ticagrelor in acute coronary syndromes: a post hoc analysis of the randomized GLOBAL LEADERS trial. JAMA Cardiol 2019;4:1092–1101.

 

Para cualquier consulta o incidencia contacte con faqs@cmep-cardiology.com

Actividad de 43 horas lectivas acreditada con 5,8 créditos de formación continuada por la Comisión de Formación Continuada de las Profesiones Sanitarias de la Comunidad de Madrid - Sistema Nacional de Salud (Exp. núm. 07-AFOC-00649.8/2021)